Zhonghua Tao

6PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Targeting arginine metabolism reverses bone immunosuppressive microenvironment and metastasis in ARID1A-deficient triple negative breast cancer.

|Mar 04, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Ting Li, Teng Zhou, Biyun Wang

|Nov 24, 2025
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China.

Chengcheng Gong, Ting Li, Yifan Chen

|Mar 04, 2025
Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

Yizhao Xie, Zhonghua Tao, Biyun Wang

|Jun 20, 2024
Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer.

Ganfei Xu, Rui Huang, Reziya Wumaier

|Jul 12, 2023
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.

Xin-Yu Chen, Bin Li, Ye Wang

Pageof 1

Frequent Collaborators

3 joint publications

Biyun Wang

3 joint publications

Xichun Hu

2 joint publications

Chengcheng Gong

1 joint publications

Ganfei Xu